Pharma Journalist -

PTC Therapeutics and Akcea Therapeutic an affiliate of Ionis Pharmaceuticals announced a collaboration under which PTC will commercialize two of Akcea's rare disease drugs in Latin…
Read More...

Roche announced that the European Medicines Agency (EMA) has granted PRIME (PRIority MEdicines) designation for the company’s investigational medicine RG6042 (formerly known as…
Read More...

Novartis announced that the European Commission (EC) approved Aimovig (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month. Aimovig is…
Read More...

AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside the US and Canada) announced that the European Medicines Agency (EMA) has granted orphan designation to…
Read More...

Takeda Pharmaceutical Company Limited announced the opening of a production site for NINLARO (ixazomib), an innovative drug for patients with multiple myeloma, at its Yaroslavl plant.…
Read More...

Pfizer Inc. announced the European Commission (EC) has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor (HER2)…
Read More...

Shionogi & Co., Ltd. announced that, after completing a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Mulpleta (lusutrombopag), a once-daily, orally…
Read More...

Abdi Ibrahim has carefully selected rfxcel to implement and support new compliance management and serialisation processing software to ensure full compliance with current and future…
Read More...

Torque, an immuno-oncology company developing first-in-class Deep Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today a…
Read More...

Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel medicines targeting metalloenzymes, announced that, based on achievement of technical milestones, it has…
Read More...